Mirtazapine Tablet, Film Coated
Product Images NDC 57237-009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 57237-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (7.5 mg (100 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (15 mg (100 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))

Package Label-principal Display Panel (30 mg (100 Tablet Bottle))
Rising® N0c57237-009-30 is a medication containing 30mg of Mirtazapine USP. The usual dosage is enclosed and made in India, and prescribing information can be found on the tablet. The tablets are marked with the code TS/DRUGS/19/1093, and should be dispensed in a tight, light-resistant container as described in the USP. The medication guide is provided, and the tablets should be stored at between 15°C to 30°C. This information was last revised on 12/12/2019.*
FDA Label Image

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))

Package Label-principal Display Panel (45 mg (100 Tablet Bottle))
Rising® N0c57237-010-30 is a medication distributed by Rising Health, LLC. Each tablet contains 45 mg of Mirtazapine USP. It is recommended to read the enclosed prescribing information for the usual dosage. It is coded as TS/DRUGS/19/1093 Tablets, USP. The medication should be dispensed in a tight, light-resistant container as described in the USP. The pharmacist should dispense the medication with the medication guide provided. Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. This text seems to be a medication label.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.